Good morning, everyone, and welcome to another working week. We hope the weekend respite was refreshing and invigorating, because that predictable routine of online calls, meetings, and deadlines has, of course, returned. But you know the drill — the world keeps spinning, so find a way to remain on board. We do this by quaffing cups of stimulation and our choice today is the ever-so-sweet glazed doughnuts. Yes, this is a real flavor. So time to get cracking. Here is the latest laundry list of interesting items to help you on your own journey. We hope you have a meaningful and productive day. And please do keep in touch. Even in this day and age, postcards and telegrams are useful. …
When it comes to executive compensation in the biotech and pharma sectors, it pays to be the chief executive officer at Regeneron Pharmaceuticals, STAT tells us. Len Schleifer, took home $453 million in 2021, more than any other executive in the sector, which represents just less than the entire combined compensation — $478 million — of the next nine highest-paid chief executive officers. In addition to salary, cash-based bonuses, and other perks, total compensation was calculated by using the “actual realized gains” of stock options and awards, instead of the estimated fair value of those options and awards that is more commonly reported.
Continue to STAT+ to read the full story…
Click this link for the original source of this article.
Author: Ed Silverman
This content is courtesy of, and owned and copyrighted by, https://www.statnews.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.
